Revolo Biotherapeutics KOL Event on ‘1104: A First-in-Class Peptide for Eosinophilic Esophagitis (EoE) & Allergen Sensitivity
About The Event
Please join us for a virtual KOL event with Revolo Biotherapeutics, featuring Evan Dellon, MD, MPH (University of North Carolina School of Medicine in Chapel Hill) and Mohamed Shamji, PhD (Professor of Immunology and Allergy at Imperial College London). The event will discuss disease pathogenesis, the unmet medical needs, the current treatment landscape and Revolo’s recent positive phase 2a clinical data in patients suffering from EoE as well as the broad mechanistic effects of ‘1104 in allergy.
A live question and answer session will follow the formal presentations.